サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1712506

コンピュータ断層撮影の世界市場：2025年～2033年

Global Computed Tomography Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
コンピュータ断層撮影の世界市場：2025年～2033年
出版日: 2025年04月22日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のコンピュータ断層撮影の市規模場は、2024年に43億9,000万米ドルとなりました。同市場は、2033年には82億1,000万米ドルに達し、2025年～2033年の予測期間中のCAGRは7.6%となる見込みです。

CATスキャンとしても知られるコンピュータ断層撮影法（CT）は、患者に向けて照射される細いX線ビームを利用する高度な画像技術であり、このビームは身体の周りを高速で回転します。この過程で発生する信号をコンピュータで処理し、"スライス"と呼ばれる断面画像を作成します。これらの断層画像は、従来のX線画像に比べてより詳細な情報を臨床医に提供します。

検査中、CT装置のコンピューターは複数の連続したスライスを撮影します。そして、これらのスライスをデジタル処理で合成することにより、患者の解剖学的構造を3次元（3D）で表現することができます。この3D画像により、基本的な構造だけでなく、潜在的な腫瘍や異常も容易に特定できるため、診断精度が向上し、治療計画も立てやすくなります。

CT技術の革新は、世界のコンピュータ断層撮影市場の重要な促進要因です。ハイスライススキャナー、デュアルエナジーCT、人工知能の統合など、CT技術における継続的な技術革新は、画像品質と診断精度を大幅に向上させる。さらに、業界の主要企業は、この市場成長を促進する技術革新を統合しています。

例えば、2024年6月、FUJIFILM Healthcare Americas Corporationは、FCT iStreamとして知られるコンパクトな128スライスCTシステムを発売し、コンピュータ断層撮影（CT）市場で注目すべき進歩を遂げました。このシステムはFDAの510（k）認可を取得し、臨床現場での使用が可能になっています。

さらに、Philipsは2024年2月、欧州放射線学会（ECR）2024でAI対応CT 5300システムを発表し、診断精度を向上させるとともに、高度な画像診断をより手頃な価格で幅広い患者に提供できるようにしました。この革新的なシステムは、臨床環境における効率的かつ効果的な画像ソリューションに対する需要の高まりに応えるように設計されています。

高度なコンピュータ断層撮影（CT）システムの購入と設置に伴う高額なコストは、多くのヘルスケア施設、特に小規模のクリニックや病院にとって大きな障壁となっています。この初期投資により、特にリソースに制約のある環境では、最新の画像技術へのアクセスが制限される可能性があります。

CTスキャナーのコストを理解するには、様々な選択肢を検討する必要があり、それぞれが特定の画像ニーズを満たし、様々な予算に対応するように設計されています。CTスキャナーには3つの価格帯（エントリーレベル、インターミディエイト、プレミアム）があります。各カテゴリーは価格帯だけでなく、提供される技術や診断機能のレベルによっても定義され、ヘルスケア施設に業務要件に沿った選択肢を提供しています。

2024年のBlock Imaging, Inc.のデータによると、エントリーレベルのCTスキャナーは最も入手しやすい選択肢であり、価格は8万米ドルから10万米ドルです。中級CTスキャナーの価格は12万米ドルから16万米ドルで、より高度な技術と機能を提供します。一方、20万米ドルから30万米ドルのCTスキャナーのプレミアム層は、より複雑な診断ニーズに対応する高度な画像技術を特徴としています。

当レポートでは、世界のコンピュータ断層撮影市場について調査し、市場の概要とともに、タイプ別、技術別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーとパイオニア
  • 最新の開発とブレークスルー
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向

第5章 コンピュータ断層撮影市場（タイプ別）

  • 据置型CT
  • 可動型CT

第6章 コンピュータ断層撮影市場（技術別）

  • ハイスライスCT
  • ミッドスライスCT
  • ロースライスCT
  • コーンビームCT（CBCT）

第7章 コンピュータ断層撮影市場（用途別）

  • 腫瘍
  • 心臓病
  • 新興医療
  • 神経血管
  • 筋骨格
  • その他

第8章 コンピュータ断層撮影市場（エンドユーザー別）

  • 病院
  • 診断画像センター
  • その他

第9章 コンピュータ断層撮影市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Siemens Healthcare Private Limited
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • GE HealthCare.
  • Canon Medical Systems, USA.
  • Koninklijke Philips NV
  • FUJIFILM India Private Limited
  • Neusoft Medical Systems
  • United Imaging Healthcare Co., Ltd.
  • Koning Health.
  • NeuroLogica Corp.
  • Shenzhen Anke High-tech Co., Ltd.
  • Planmed Oy
  • Stryker

第12章 仮定と調査手法

第13章 付録

目次
Product Code: MA245

The global computed tomography market reached US$ 4.39 billion in 2024 and is expected to reach US$ 8.21 billion by 2033, growing at a CAGR of 7.6 % during the forecast period of 2025-2033.

Computed tomography (CT), also known as computerized axial tomography (CAT), is a sophisticated imaging technique that utilizes a narrow beam of X-rays directed at a patient, which rapidly rotates around the body. This process generates signals that are processed by a computer to create cross-sectional images, referred to as "slices." These tomographic images provide clinicians with more detailed information compared to conventional X-rays.

During the procedure, the CT machine's computer captures multiple successive slices. These slices can then be digitally combined to form a three-dimensional (3D) representation of the patient's anatomy. This 3D imaging facilitates the easier identification of fundamental structures, as well as potential tumors or abnormalities, thereby enhancing diagnostic accuracy and aiding in treatment planning.

Market Dynamics: Drivers & Restraints

Innovations in CT Technology

Innovations in CT technology are crucial drivers for the global computed tomography market. Ongoing innovations in CT technology, such as high-slice scanners, dual-energy CT, and the integration of artificial intelligence, significantly improve imaging quality and diagnostic accuracy. Furthermore, key players in the industry integrate innovations in the technology that would drive this market growth.

For instance, in June 2024, FUJIFILM Healthcare Americas Corporation made notable advancements in the computed tomography (CT) market by launching its compact, 128-slice CT system known as the FCT iStream. This system has received FDA 510(k) clearance, allowing it to be utilized in clinical settings.

Additionally, in February 2024, Philips unveiled the AI-enabled CT 5300 system at the European Congress of Radiology (ECR) 2024 to improve diagnostic accuracy while making advanced imaging more affordable and accessible to a broader range of patients. This innovative system is designed to meet the increasing demand for efficient and effective imaging solutions in clinical environments.

High Costs of Equipment

The high costs associated with purchasing and installing advanced computed tomography (CT) systems create a significant barrier for many healthcare facilities, particularly smaller clinics and hospitals. This initial investment can restrict access to the latest imaging technologies, especially in resource-constrained environments.

Understanding the cost of a CT scanner involves navigating various options, each designed to meet specific imaging needs and accommodate different budgets. There are three distinct price tiers for CT scanners: Entry Level, Intermediate, and Premium. Each category is defined not only by its price range but also by the level of technology and diagnostic capabilities offered, providing healthcare facilities with choices that align with their operational requirements.

According to the Block Imaging, Inc. data in 2024, stated that entry-level CT scanners are the most accessible option, with prices ranging from $80,000 to $100,000. The intermediate tier of CT scanners, priced between $120,000 and $160,000, provides enhanced technology and capabilities. Meanwhile, the premium tier of CT scanners, which range from $200,000 to $300,000, features advanced imaging technologies for more complex diagnostic needs.

Segment Analysis

The global computed tomography market is segmented based on type, technology, application, end-user, and region.

Technology:

The high-slice CT segment in technology is expected to dominate the global computed tomography market with the highest market share

High-slice CT scanners, typically encompassing systems with more than 128 slices (such as 256-, 320-, and 640-slice models), these systems offer faster scan times, increased patient throughput, and lower radiation doses, making them ideal for advanced diagnostic imaging across multiple medical disciplines, including cardiology, neurology, oncology, gastroenterology, and pediatrics.

High-slice CT scanners provide enhanced image clarity, which is crucial for detecting microcalcifications, vascular abnormalities, and early-stage cancers. Innovations such as AI integration, improved dose reduction techniques, and photon-counting CT technology (as seen in Siemens Healthineers' Naeotom Alpha series) are propelling this segment forward. These CT scanners are highly valuable for non-invasive coronary imaging, offering precise assessment of cardiovascular diseases, particularly in patients with irregular heart rates.

For instance, in December 2024, Siemens Healthineers' introduction of the Naeotom Alpha.Pro and Naeotom Alpha. Prime represents a breakthrough in high-slice CT imaging by integrating photon-counting detector (PCD) technology into the field. These additions mark a significant advancement in CT imaging, offering higher resolution, reduced radiation dose, and improved workflow efficiency.

High-slice CT scanners, such as 128-slice, 256-slice, and 320-slice systems, capture large volumes of data with greater speed and resolution. However, conventional high-slice CT scanners still rely on energy-integrating detectors (EIDs), which have limitations in signal processing and image quality. These factors have solidified the segment's position in the global computed tomography market.

Geographical Analysis

North America is expected to hold a significant position in the global computed tomography market with the highest market share

The increasing incidence of chronic illnesses, such as cancer and cardiovascular diseases, is a major driver of CT scanner demand. In particular, oncology applications are seeing significant growth due to higher rates of cancer diagnoses and expanded screening programs, such as low-dose CT scans for lung cancer detection in high-risk groups.

North America, especially the U.S., is witnessing rapid advancements in CT scanner technology, including AI-powered image analysis, photon-counting detectors, and improved resolution with lower radiation doses. Companies like Siemens Healthineers, GE Healthcare, and Canon Medical Systems are investing heavily in research and innovation.

The U.S. government and private institutions are increasing investments in healthcare infrastructure, particularly in advanced diagnostic imaging. The National Institute of Health (NIH) has allocated billions of dollars for cancer and cardiovascular disease research, further boosting the adoption of CT imaging for early disease detection.

Furthermore, key players' product launches and approvals would drive this market growth. For instance, in June 2025, Fujifilm Healthcare Americas Corporation received FDA 510(k) clearance for its new 128-slice computed tomography (CT) system, the FCT iStream. This CT system is designed to provide high-quality imaging while enhancing efficiency and reducing patient radiation exposure. Thus, the above factors are consolidating the region's position as a dominant force in the global computed tomography market.

Competitive Landscape

The major global players in the computed tomography market include Siemens Healthcare Private Limited, GE HealthCare, Canon Medical Systems, USA., Koninklijke Philips N.V., FUJIFILM India Private Limited, Neusoft Medical Systems, United Imaging Healthcare Co., Ltd., Koning Health, NeuroLogica Corp., Shenzhen Anke High-tech Co., Ltd., Planmed Oy, and Stryker among others.

Key Developments

  • In December 2024, CarePlus International Clinics officially inaugurated a cutting-edge Diagnostic Imaging Center that features MRI and CT scan services integrated with advanced Artificial Intelligence (AI) technology. The integration of AI into these imaging technologies is expected to improve the accuracy and efficiency of diagnostic procedures, ultimately benefiting patient care and health outcomes.
  • In July 2024, Trivitron Healthcare reached a significant milestone by becoming the first Indian company to secure regulatory approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB), and the Central Drugs Standard Control Organization (CDSCO) for the manufacturing of CT scanners.
  • In February 2024, Koning Health announced that it had received regulatory clearance from the Federal Authority for Nuclear Regulation (FANR) in the United Arab Emirates (UAE). This approval enables Koning to introduce its innovative breast computed tomography (CT) technology, specifically the Vera Complete system, into the UAE market.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global computed tomography market report delivers a detailed analysis with 76 key tables, more than 67 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Innovations in CT Technology
      • 3.1.1.2. Rising Prevalence of Chronic Diseases
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Equipment
      • 3.1.2.2. Strict Regulatory Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Increasing Demand for Preventive Healthcare
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Latest Developments and Breakthroughs
  • 4.3. Regulatory and Reimbursement Landscape
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. Asia Pacific
    • 4.3.4. South America
    • 4.3.5. Middle East & Africa
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Supply Chain Analysis
  • 4.6. Patent Analysis
  • 4.7. SWOT Analysis
  • 4.8. Unmet Needs and Gaps
  • 4.9. Recommended Strategies for Market Entry and Expansion
  • 4.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.11. Pricing Analysis and Price Dynamics

5. Computed Tomography Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Stationary CT *
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Portable CT

6. Computed Tomography Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. High-Slice CT*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mid-Slice CT
  • 6.4. Low-Slice CT
  • 6.5. Cone Beam CT (CBCT)

7. Computed Tomography Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Oncology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Emerging Medicine
  • 7.5. Neurovascular
  • 7.6. Musculoskeletal
  • 7.7. Others

8. Computed Tomography Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Others

9. Computed Tomography Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Siemens Healthcare Private Limited*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. GE HealthCare.
  • 11.3. Canon Medical Systems, USA.
  • 11.4. Koninklijke Philips N.V.
  • 11.5. FUJIFILM India Private Limited
  • 11.6. Neusoft Medical Systems
  • 11.7. United Imaging Healthcare Co., Ltd.
  • 11.8. Koning Health.
  • 11.9. NeuroLogica Corp.
  • 11.10. Shenzhen Anke High-tech Co., Ltd.
  • 11.11. Planmed Oy
  • 11.12. Stryker

LIST NOT EXHAUSTIVE

12. Assumptions and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us